Eyepatch having effect of improving eyesight for myopia and presbyopia and preparation method of eyepatch

Abstract

The invention relates to an eyepatch having the effect of improving eyesight for myopia and presbyopia and a preparation method of the eyepatch. The eyepatch comprises an eyepatch main body, an eyepatch front lens frame, elastic silica gel eyepatch patches, an elastic headgear belt, a glass body lens, elastic silica gel eyepatch patch holes, cold treatment gasifying crystal boxes, cold treatment gasifying crystals, cold treatment gasifying crystal box fixing pins, cold treatment gasifying crystal box covers, cold treatment gasifying crystal box sight holes, cold treatment gasifying crystal boxcover smoking treatment gasifying holes, cold treatment gasifying crystal box cover sight holes, fixing brackets, exchangeable lens antifogging holes, and exchangeable lens cold treatment gasifying crystal box cover sight holes, wherein the cold treatment gasifying crystals in the cold treatment gasifying crystal boxes are prepared from ambroxide, L-N-borneol and the like, the eyepatch can achieve the purpose that people suffering from myopia, presbyopia and cataract at the initial phase and with 0.8 or below of eightsight do not need to wear lens after the eyepatch is used for 1-16 treatmentcourses, and 90% or above of normal eyesight can be returned. After wearing the cold treatment gasifying crystal eyepatch for 35 minutes, different people suffering from myopia, presbyopia and cataract can realize the purpose of eyesight improvement by 50%-30% after the eyepatch is unfixed, and the effective rate is 99.9%. The eyepatch particularly has effective effects on eyesight improvement ofpeople suffering from myopia and presbyopia.

Description

technical field [0001] The invention belongs to the technical field of medical devices, in particular to a vision-enhancing eye mask for myopia and presbyopia and a preparation method thereof. Background technique [0002] A research report by the World Health Organization shows that age-related macular degeneration is the third leading cause of blindness in the world after cataracts and glaucoma. It can cause disease in all age groups, and mainly occurs in people over 45-50 years old. The global age-related macular degeneration market research report shows that age-related macular degeneration is growing at a compound annual growth rate of 9.62%. The latest domestic survey on the incidence of age-related macular degeneration is a survey report published in 2018. The survey results show that the prevalence rate of people over 45 years old in my country is 7.96% to 25.13%. my country has a large population base, and the aging population is getting more and more serious. The...

AI Technical Summary

Problems solved by technology

[0012] In order to overcome the existing domestic and foreign technologies such as glasses, eye masks, eye patches, eye drops, etc., the eyesight of myopia, presbyopia, and cataract at the initial stage (0.8) cannot be removed for recovery, and medium-term myopia, presbyopia, and cataract cannot be relieved. The vitreous injection is expensive, and the operation is troublesome and risky, especially when wearing glasses, goggles, and eye patches Does not relieve major deficits in vision

Images